Investor · 1 deal
Every published round Biointelect took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies Biointelect has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| ENA Respiratory | Antiviral nasal spray to prevent severe respiratory viral infections | 1 Sep 2026, Grant | 1 | 0 |
Fund closes reported for Biointelect, as distinct from the investments it has made.
Companies Biointelect has backed that another company then bought. An exit for the holding, not a deal Biointelect did.
| Name | Role | Sources |
|---|---|---|
| Leah Goodman | CEO | Mirage News |
Stories naming Biointelect. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
UQ spinout Proboxis Biotechnology has received $1.5 million via the first round of the Biointelect Venturer incubator to advance a vaccine platform against mosquito-borne diseases toward human clinical development.